The latest price target for Fractyl Health (NASDAQ:GUTS) was reported by Evercore ISI Group on February 28, 2024. The analyst firm set a price target for $0.00 expecting GUTS to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.

The latest analyst rating for Fractyl Health (NASDAQ:GUTS) was provided by Evercore ISI Group, and Fractyl Health initiated their outperform rating.

There is no last upgrade for Fractyl Health

There is no last downgrade for Fractyl Health.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Fractyl Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Fractyl Health was filed on February 28, 2024 so you should expect the next rating to be made available sometime around February 28, 2025.

While ratings are subjective and will change, the latest Fractyl Health (GUTS) rating was a initiated with a price target of $0.00 to $0.00. The current price Fractyl Health (GUTS) is trading at is $2.08, which is out of the analyst’s predicted range.